Pfizer Inc and BioNTech SE's coronavirus vaccine is effective at blocking the disease and vaccinated people showed 'dramatically lower' rates of infection, a new study finds. Researchers from the companies, who teamed up with the Israeli Ministry of Health, said on Thursday that the COVID-19 was 97 perfect effective at preventing symptomatic cases, hospitalizations and deaths. Those who were unvaccinated were 44 times more likely to develop symptomatic COVID-19 and 29 times more likely to die from the disease, researchers also found. Pfizer Inc and BioNTech SE's coronavirus vaccine prevented 97% of symptomatic cases, hospitalizations and deaths. The study was conducted from data collected between January 17 and March 6, 2021, when the Pfizer-BioNTech vaccine was the only vaccine available in Israel.

Source: Daily Mail March 11, 2021 13:20 UTC